What is a Significant Financial Interest (SFI)?

A financial interest is anything of monetary value – whether that value can be easily determined or not – that belongs to any of the following: the investigator, the investigator’s spouse, any dependent children. The financial interest becomes significant when it meets any of the following definitions:

  • You (as defined above) receive income from and/or hold equity in a publicly traded entity that, in aggregate, meets or exceeds $5,000 in value during the 12 months prior to your RCOI disclosure
    • Equity (stock, stock options, or other ownership interest) valued at $5,000 or more
    • Remuneration valued at $5,000 or more in the last 12 months
    • A combination of remuneration and equity – with respect to a single entity – that is valued at $5,000 or more.
  • You hold equity interest in a non-publicly traded entity (any amount).
  • You received remuneration valued at $5,000 or more from an outside entity during the 12 months prior to your RCOI disclosure.
  • You received remuneration from an outside entity for intellectual property rights and interests (including but not limited to patents, copyrights, royalties, licencing fees) during the 12 months prior to disclosure.
  • Your travel costs were funded (reimbursed or sponsored) by an outside entity during the 12 months prior to disclosure.

You do not have to include the following in your disclosure, as they will not be considered significant financial interests:

  • Salary, royalties, or other remuneration funded by CSU
  • Income from passive investment vehicles, such as mutual funds or retirements accounts, where you not directly control the investment decisions
  • Income, remuneration, or travel funding received from US-based government agencies (any level); US-based higher education institutions; and academic research institutes, teaching hospitals, and medical centers associated with US higher education institutions.
  • Agency for Healthcare Research and Quality (AHRQ)
  • Agency for Toxic Substances and Disease Registry (ATSDR)
  • Centers for Disease Control and Prevention (CDC)
  • Food and Drug Administration (FDA)
  • Health Resources and Services Administration (HRSA)
  • Indian Health Service (IHS)
  • National Institutes of Health (NIH)
  • Office of Global Affairs (OG)
  • Office of the Assistant Secretary for Health (OASH)
  • Office of the Assistant Secretary for Planning and Evaluation
  • Office of the Assistant Secretary for Preparedness and Response (ASPR)
  • Office of Public Health and Science
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Administration for Children & Families
  • Administration on Aging
  • Centers for Medicare & Medicaid Services
  • Alliance for Lupus Research (ALR)
  • Alpha-1 Foundation
  • American Asthma Foundation
  • American Cancer Society (ACS)
  • American Heart Association (AHA)
  • American Lung Association (ALA)
  • Arthritis Foundation (AF)
  • CurePSP
  • Juvenile Diabetes Research Foundation (JDRF)
  • Lupus Foundation of America (LFA)
  • Patient Centered Outcome Research Institute (PCORI)
  • Susan G. Komen for the Cure
Cam the Ram logo

Travel Information

Significant Financial Interest (SFI):

Travel costs were funded by an outside entity during the 12 months prior to disclosure and travel was paid on behalf of the reporter instead of reimbursed. *See note about non-SFI travel exceptions below.

Sponsored or reimbursed travel greater than $5,000 when aggregated annually

Not a Significant Financial Interest:

Travel (less than $5,000 when aggregated annually) sponsored or paid by a federal, state or local government agency, a qualifying institution of higher education, an academic teaching hospital, a medical center or a research institute that is affiliated with a qualifying institution of higher education.

Special note for Public Health Service (PHS) PI, Co-PI, or Key Personnel:

PHS requires the disclosure of reimbursed or sponsored travel for PHS-funded investigators within 30 days of the occurrence of the travel.  The travel must be related to the investigator’s institutional responsibilities and be funded by an entity other than: a U.S.-based Federal, state or local government agency, an institution of higher education, an academic teaching hospital, a medical center, or a research institute that is affiliated with an institution of higher education.

Important Note: If the travel is sponsored or reimbursed by an entity that receives money from a U.S.-based government agency, institution of higher education, or any other excluded entities listed above, you must still disclose the travel when those funds come directly from a non-exempted entity (e.g., you travel to a workshop funded by a federal funding agency, but your travel is funded by a professional society).